BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2966802)

  • 1. Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation.
    Beckmann R; Geiger M; Binder BR
    J Biol Chem; 1988 May; 263(15):7176-80. PubMed ID: 2966802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R; Geiger M; de Vries C; Pannekoek H; Binder BR
    J Biol Chem; 1991 Feb; 266(4):2227-32. PubMed ID: 1824940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen.
    Grailhe P; Nieuwenhuizen W; Anglés-Cano E
    Eur J Biochem; 1994 Feb; 219(3):961-7. PubMed ID: 8112348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
    Kirchheimer JC; Resch I; Christ G; Wojta J; Binder BR
    Eur J Biochem; 1987 Jul; 166(2):393-7. PubMed ID: 3609016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
    Lee PP; Wohl RC; Boreisha IG; Robbins KC
    Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
    Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
    Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sequence A alpha-(154-159) of fibrinogen is capable of accelerating the t-PA catalysed activation of plasminogen.
    Schielen WJ; Adams HP; Voskuilen M; Tesser GI; Nieuwenhuizen W
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):465-70. PubMed ID: 1932532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin-mediated plasminogen activation.
    Nieuwenhuizen W
    Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains.
    Ries M; Easton RL; Longstaff C; Zenker M; Corran PH; Morris HR; Dell A; Gaffney PJ
    Thromb Res; 2001 Aug; 103(3):173-84. PubMed ID: 11672579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
    Fischer B
    Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1067-75. PubMed ID: 2128181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activation in diabetes mellitus: kinetics of plasmin formation with plasminogen and tissue plasminogen activator from diabetic donors.
    Geiger M; Binder BR
    Semin Thromb Hemost; 1991 Oct; 17(4):417-21. PubMed ID: 1839461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of tissue-type plasminogen activator to fibrinogen fragments.
    Bosma PJ; Rijken DC; Nieuwenhuizen W
    Eur J Biochem; 1988 Mar; 172(2):399-404. PubMed ID: 3127207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization in the fibrinogen gamma-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen.
    Yonekawa O; Voskuilen M; Nieuwenhuizen W
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):187-91. PubMed ID: 1567367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE; Will H
    Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.
    Suenson E; Petersen LC
    Biochim Biophys Acta; 1986 Apr; 870(3):510-9. PubMed ID: 2938632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
    Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
    Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.